12:00 AM
 | 
Feb 23, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Neural stem cell therapy: Phase I data

Data from a Phase I trial in a male patient with idiopathic advanced PD showed that autologous neural stem cell suspensions containing differentiated dopaminergic and GABAergic neurons, when implanted by microinjection unilaterally into the left putamen of the patient's brain, improved the overall Unified Parkinson's...

Read the full 202 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >